Discoordinate regulation of different K channels in cultured rat skeletal muscle by nerve growth factor.
We investigated the effects of nerve growth factor (NGF) on expression of K+ channels in cultured skeletal muscle. The channels studied were (1) charybdotoxin (ChTx)-sensitive channels by using a polyclonal antibody raised in rabbits against ChTx, (2) Kv1.5 voltage-sensitive channels, and (3) apamin-sensitive (afterhyperpolarization) channels. Crude homogenates were prepared from cultures made from limb muscles of 1-2-day-old rat pups for identification of ChTx-sensitive and Kv1.5 channels by Western blotting techniques. Apamin-sensitive K+ channels were studied by measurement of specific [125I]-apamin binding by whole cell preparations. ChTx-sensitive channels display a fusion-related increase in expression, and NGF downregulates these channels in both myoblasts and myotubes. Voltage-dependent Kv1.5 channel expression is low in myoblasts and increases dramatically with fusion; NGF induces early expression of these channels and causes expression after fusion to increase even further. NGF downregulates apamin-sensitive channels. NGF increases the rate of fall of the action potential recorded intracellularly from single myotubes with intracellular microelectrodes. The results confirm and extend those of previous studies in showing a functional role for NGF in the regulation of membrane properties of skeletal muscle. Moreover, the findings demonstrate that the different K+ channels in this preparation are regulated in a discoordinate manner. The divergent effects of NGF on expression of different K+ channels, however, do not appear sufficient to explain the NGF-induced increase in the rate of fall of the action potential. The changes during the falling phase may rather be due to increases in channel properties or may result from an increased driving force on the membrane potential secondary to the NGF-induced hyperpolarization.
Vigdor-Alboim
S
S
Otto Meyerhoff Center, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Rothman
C
C
Braiman
L
L
Bak
A
A
Langzam
L
L
Yosef
O
O
Sterengarz
B B
BB
Nawrath
H
H
Brodie
C
C
Sampson
S R
SR
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000831:Animals, Newborn; D001030:Apamin / Q000378:metabolism; D001665:Binding Sites; D002459:Cell Fusion; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D018999:Charybdotoxin / Q000378:metabolism / Q000494:pharmacology; D004594:Electrophysiology; D015870:Gene Expression / Q000187:drug effects; D015640:Ion Channel Gating / Q000187:drug effects; D051666:Kv1.5 Potassium Channel; D008970:Molecular Weight; D018485:Muscle Fibers, Skeletal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D018482:Muscle, Skeletal / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D009414:Nerve Growth Factors / Q000494:pharmacology*; D015221:Potassium Channels / Q000378:metabolism* / Q000502:physiology*; D024642:Potassium Channels, Voltage-Gated; D051381:Rats
C496983:Kcna5 protein, rat; D051666:Kv1.5 Potassium Channel; D009414:Nerve Growth Factors; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; C087375:charybdotoxin receptor; D018999:Charybdotoxin; D001030:Apamin